Angiosarcoma News and Research

RSS
Angiosarcoma is a type of cancer that begins in the cells that line blood vessels or lymph vessels. Cancer that begins in blood vessels is called hemangiosarcoma. Cancer that begins in lymph vessels is called lymphangiosarcoma.
New Kaposi sarcoma mouse model could be key to drug development

New Kaposi sarcoma mouse model could be key to drug development

MGI Partners with National Cancer Centre Singapore to Undergo Comprehensive Genomic Profiling of Asian-Prevalent Cancers

MGI Partners with National Cancer Centre Singapore to Undergo Comprehensive Genomic Profiling of Asian-Prevalent Cancers

SWOG investigators report results from DART clinical trial of immunotherapy combination for rare gynecologic cancers

SWOG investigators report results from DART clinical trial of immunotherapy combination for rare gynecologic cancers

Study finds durable responses to immunotherapy in rare angiosarcomas

Study finds durable responses to immunotherapy in rare angiosarcomas

University of Louisville receives NIH funding to support research into liver-related illness

University of Louisville receives NIH funding to support research into liver-related illness

Scientists identify distinct sub-types of angiosarcomas to allow for targeted treatment

Scientists identify distinct sub-types of angiosarcomas to allow for targeted treatment

Immunotherapies effective against lung cancer, melanoma may also work against rare skin tumor

Immunotherapies effective against lung cancer, melanoma may also work against rare skin tumor

Immunotherapy combination shrinks rare angiosarcoma tumors in 25% of patients

Immunotherapy combination shrinks rare angiosarcoma tumors in 25% of patients

Finding the origins of angiosarcoma

Finding the origins of angiosarcoma

New project identifies immune checkpoint inhibition as potential treatment for angiosarcomas

New project identifies immune checkpoint inhibition as potential treatment for angiosarcomas

Oncologists discover cell type that gives rise to soft tissue cancer in children

Oncologists discover cell type that gives rise to soft tissue cancer in children

Common drug for high blood pressure repurposed to treat soft tissue sarcoma in Europe

Common drug for high blood pressure repurposed to treat soft tissue sarcoma in Europe

ESMO Asia 2016: Three studies present first data on rare sarcomas in Asian patients

ESMO Asia 2016: Three studies present first data on rare sarcomas in Asian patients

Cancer experts to discuss novel treatment strategies at ESMO Asia 2016 Congress

Cancer experts to discuss novel treatment strategies at ESMO Asia 2016 Congress

Common beta-blocker prescribed for heart conditions has anti-cancer properties, study shows

Common beta-blocker prescribed for heart conditions has anti-cancer properties, study shows

Common heart drug may halt progression of angiosarcoma

Common heart drug may halt progression of angiosarcoma

Researchers find mutated gene responsible for cardiac angiosarcoma in two brothers

Researchers find mutated gene responsible for cardiac angiosarcoma in two brothers

Researchers identify two novel genes associated with development of rare, aggressive blood cancer

Researchers identify two novel genes associated with development of rare, aggressive blood cancer

UNC researchers develop new radiation-free ultrasound technique to detect, monitor cancer

UNC researchers develop new radiation-free ultrasound technique to detect, monitor cancer

New investigational drug offers potential treatment option for lung cancer

New investigational drug offers potential treatment option for lung cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.